Chronic Kidney Disease of Uncertain Etiology

Key Points

  • A number of geographic regions around the world have an unexpectedly high prevalence of kidney disease among persons without previously identified risk factors for kidney disease.

  • Agricultural work is the predominant occupation in three of the best-studied hotspots: Pacfic-Coast Central America, North Central and Central Province, Sri Lanka, and Uddanam region within Andhra Pradesh, India.

  • Kidney biopsy series, though small in number, indicate tubulointersitial disease with variable degrees of glomeruloscelorisis across all three regions.

  • Accurate assessments of prevalence and incidence are challenging, in part due to resource limitations but also due to lack of clear demographic or clinical (laboratory-based) parameters distinguishing chronic kidney disease from chronic kidney disease of unknown etiology.

  • Several hypotheses regarding cause are under study, including recurrent heat stress; exposure to ground water toxin; or infection. The investigation of these hypothesized causes necessitates collaborations across occupational health, environmental epidemiology, and nephrology, in addition to a number of large international studies building scienitific resources and capacity in otherwise underresourced regions.

Since the latter part of the 20th and early 21st century, nephrologists have identified a progressive kidney disease, primarily tubulointerstitial on kidney biopsy, occurring in specific regions of South Asia and Central America, and among persons without previously identified risk factors for kidney disease. Much remains unknown and unclear about this disease, starting from nomenclature. In this chapter we use the term “Chronic Kidney Disease of Uncertain Etiology (CKDu)” but the terms Meso-American endemic Nephropathy (MeN), Uddanam Nephropathy, and Chronic interstitial nephritis in agricultural communities (CINAC) are also commonly used. “CKDu” is an inherently broad and opaque term. In this chapter, we use CKDu to refer to the highly-prevalent kidney disease in specific agricultural regions, disproportionate to the age distribution and diabetes prevalence, and in which kidney biopsies, where conducted, have demonstrated primarily tubulointerstitial kidney disease. We distinguish this entity from many other patients with “unknown” CKD, which could occur due to late presentation or lack of access to diagnostic testing, and other known causes of tubulointerstitial kidney disease such as hypersensitivity reaction to antibiotics or autoimmune disease such as sarcoidosis.

A number of other “endemic” regional nephropathies might historically have met criteria for CKDu until the cause was identified. These include unregulated release of cadmium into the Jintsu river during World War II in Japan, leading to contaminated rice paddy fields and an outbreak of “itai-itai” disease; lead nephropathy due to lead-based paint used in verandas in Queensland, Australia; and aristolochic acid nephropathy in the Balkans in the 1940s where a nephrotoxic weed growing in the wheat fields was admixing with families’ flour. Tubular injury predominated as the primary finding on biopsy in all three of these regional nephropathies. In the latter case of Balkan endemic nephropathy, although the timeline to identification of the cause was prolonged—nearly 6 decades—eventually definitive evidence emerged to identify chronic dietary exposure to aristolochic acid as the cause. Its discovery was serendipitously facilitated by a 1990s “outbreak” of rapidly progressive renal failure with tubulointerstitial nephritis among women attending a weight-loss clinic in Belgium. These women had ingested Chinese herbs, iterative analyses of which yielded the presence of aristolochic acid. Subsequent translational work identified aristolochic acid DNA adducts in affected patients’ kidney tissue or urine. Research in CKDu cause(s) is yet to identify such convincing evidence linking epidemiology to pathology and thereafter to pathophysiology, as was eventually described for Balkan endemic nephropathy.

First descriptions in three hotspot regions

From Bajo Lempa in El Salvador to Other Coastal Regions in Central America

Lacking any systematically collected end-stage kidney failure or CKD registry data, a rise in kidney disease–related hospitalizations alerted nephrologists in El Salvador to an unusual kidney disease occurring in their regions. A 1999 study in El Salvador noted that two-thirds of these patients exhibited a peculiar profile, distinguishing them from that of the classic patients with CKD: they were relatively young (mean age 51 years), mostly male (87%), agricultural workers (63%) from specific coastal regions and lacked history of diabetes or hypertension (96%). Several subsequent studies confirmed a similar profile , ( Fig. 83.1 ). Most patients seemed to come from the basin and the mouth of the Lempa River; hence the epidemic was referred to as the “Bajo Lempa nephropathy” in El Salvador ( Fig. 83.2 ). Simultaneous observations and subsequent studies demonstrated the presence of the disease in other geographic hotspots along the whole Pacific Ocean Mesoamerican coastline from southern Mexico to Panama, also comprising Guatemala, El Salvador, Nicaragua, and Costa Rica. , Many researchers and nephrologists began to group these patients together using the term “Mesoamerican endemic nephropathy (MeN) (see Chapter 74 ). ”

Fig. 83.1

(A [males] and B [females]) Examples of early epidemiologic studies evaluating chronic kidney disease of unknown etiology in Central America.

Prevalence of abnormal serum creatinine (>1.2 mg/dL for men, >0.9 mg/dL for women) in 1096 residents aged 20 to 60 years in 5 villages in northwestern Nicaragua. Villages are grouped by primary occupation.

From Torres C, Aragon A, Gonzalez M, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55(3)485–496.

Fig. 83.2

El Salvador data on mortality from kidney disease, relative to temperatures in the region.

Left: Map of El Salvador showing mortality rates per 100,000 inhabitants due to chronic kidney disease by municipality from 2011 to 2015, from white (no deaths) to dark red (highest mortality rates).

Right: Map of El Salvador showing absolute maximum temperatures, from green (24 °Celsius) to red (46° Celsius).

A from Zelaya SM, Mejía R. 2018. Mortalidad y años de vida potencialmente perdidos por enfermedades no transmisibles en El Salvador, 2011-2015. Alerta, Revista científica del Instituto Nacional de Salud. (B from National Territorial Studies Service [SNET], 2015.

Later studies described the clinical profile of the disease at earlier stages. Patients were described as presenting with cramps, paresthesia, muscle weakness, and occasionally with aseptic dysuria. , Presentation with an acute kidney injury (AKI) event has also been described, with accompanying fever and pyuria, with limited long-term follow-up data. , Blood pressure is normal referent to population averages, proteinuria is minimal or absent (except in advanced stages, when secondary glomerulosclerosis may be substantial), and hyperuricemia and electrolyte disturbances, especially hypokalemia and hyponatremia, are common. A family history of CKD is also common. In advanced stages, patients often present with elevated serum creatinine levels, variable proteinuria, important anemia, and uremia, but still with normal or only slightly elevated blood pressure, normal or low potassium levels, and absence of edema or even dehydration. Yet no single presenting feature is considered pathognomonic among clinicians practicing in the region, and the diagnosis is generally established by ruling out other common causes of CKD and/or pursuing kidney biopsy.

North Central and Central Province, Sri Lanka

Mirroring the story from El Salvador, in the mid-1990s, alarmingly high numbers of young farmers from rural communities in the North Central Province of Sri Lanka presented to the regional tertiary care hospital with uremic emergencies. There was no identifiable cause in the majority of these patients, who commonly presented with kidney failure requiring acute peritoneal dialysis as the only available treatment option. Comparing data from two regional hospitals, the number of hospitalizations for kidney failure due to unknown reasons was found to be highest among people residing in the North Central Province of the country. A population-based study of >6000 persons in three different geographical locations of the country reported on the prevalence of dipstick-detected proteinuria. Although the prevalence of dipstick-positivity was <10% in all three regions, in the surveyed North Central region a large proportion (87%) of those with dipstick-detected proteinuria did not have an identifiable cause, compared with a cause being identified in >90% with dipstick-detected proteinuria in the two other surveyed regions.

Early efforts relied on dipsticks, but given that the pathologic lesion of the disease is primarily tubulointerstitial, such screening efforts may have lacked sensitivity and specificity. Thereafter several waves of community screening and detection efforts have occurred in Sri Lanka, with variable success. Since a majority of the rural population relies on government-funded health care, which is integrated across primary to tertiary care, one report used hospital- and clinic-based case records to map the geographic distribution of CKD ( Fig. 83.3 ). Population-based data surveying the expected low and high prevalent regions based on this map indicate a prevalence of estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m 2 of up to 12% among men without diabetes or hypertension in the North Central Province. A biopsy study demonstrated that primary tubulointerstitial kidney disease was present in nearly half of kidney biopsies performed in the major tertiary center in the Central Province.

Fig. 83.3

Sri Lankan government efforts at evaluating geographic distribution of chronic kidney disease of unknown etiology.

A map of hospital and clinic-based records of numbers of patients with any chronic kidney disease by Divisional District of Sri Lanka (hospital records span 2003-2016), produced by studies conducted by Renal Disease Prevention and Research Unit, Ministry of Health, Colombo, Sri Lanka. The inset refers to numbers of patients with any chronic kidney disease.

From Ranasinghe AV, Kumara GWGP, Karunarathna RH, et al. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology [CKDu] in the North Central Province of Sri Lanka: an analysis of 30,566 patients. BMC Nephrol. 2019;20:338.

Some clear similarities exist in the demographic and clinical characteristics of Sri Lankan and Central American patients: a male predominance among those affected, reports of significant hypokalemia in the early stages, and a subset may present acutely with systemic illness. , Notable differences include a biochemical profile with hypernatremia and lack of significant hyperuricemia in Sri Lanka compared with Central America. , Table 83.1 summarizes some similarities and differences in clinical presentation and associated features on the basis of existing data from the two best-described hotspots.

Table 83.1

Similarities and Differences in Clinical Presentation and Other Associated Features of Chronic Kidney Disease of Unknown Etiology in the 2 Best-Described Hotspots

Mesoamerica Sri Lanka
Geospatial Factors
Hot, dry climate
Reliance on groundwater supply
High-density agrochemical application
Low population–based prevalence of diabetes
Clinical Presentation/Other Associated Features
Male predominance
Lack of heavy proteinuria
Significant hyperuricemia
Significant hypokalemia ?
Extensive use of NSAIDs
Specific job tasks with higher risk
Common tobacco use ?
Biopsy Data
Chronic tubulointerstitial nephritis and fibrosis
Some with primarily acute interstitial nephritis
No immune complex deposition
Significant glomerulosclerosis ?

Question mark symbols indicate lack of definitive data to make a determination.

NSAIDs, Nonsteroidal antiinflammatory drugs.

There is an interesting historical context to CKDu-endemic regions in Sri Lanka. Before 1970s, the CKDu-endemic areas in Sri Lanka were sparsely populated. Several major irrigational projects were launched to divert water from the wet zonal hill country to the north central and central dry zones for enhancing agriculture to ensure food security of the country. In parallel, there was intentional large-scale population migration from wet zonal areas to these dry zonal areas of the country. The CKDu epidemic emerged approximately 2 decades later. This historical timeline has heightened suspicions of environmental exposure, specifically water-based exposure, as a potential contributor to the epidemic.

Uddanam Region, India

Another major recognized hotspot of CKDu is in southern India, termed “Uddanam endemic nephropathy” for the specific region within Andhra Pradesh, where an endemic kidney disease was first recognized. Uddanam is a coastal region of this state, also relying primarily on agriculture but with a greater variety of crops including coconut, cashews, rice paddy, and vegetable cultivation ( Fig. 83.4 ) (see Chapter 77 ).

Fig. 83.4

Investigations in chronic kidney disease of unknown etiology in the Uddanam region, Andra Pradesh, India.

Uddanam region in the Southern state of Andhra Pradesh in an identified “hotspot” of chronic kidney disease of unknown etiology. Green dots indicate sampled villages. This study compared groundwater samples from the high-prevalence region to geographically similar areas and noted a higher prevalence of acidic, hard water with higher silica content but no evidence of significant pesticide contamination.

From Lal K, Sehgal M, Gupta V. Assessment of groundwater quality of CKDu affected uddanam region in Srikakulam district and across Andhra Pradesh, India. Groundwater Sustain Develop. 2020;11:100432.

A large cross-sectional study of more than 2400 persons from this region indicated nearly 20% of men and 16% of women had CKD, a majority (>70%) were engaged in farm work, diabetes was present in less than 20%, and family history of kidney disease was reported in 25% of the subset with eGFR <60 mL/min/1.73 m 2 . A prior study had reported similar findings. Notably, in the earlier study of 2200 persons, nearly 50% of persons with CKD had urine-to-protein creatinine ratios <0.2 g/g. A small case series confirmed that the primary findings among five men and one woman on biopsy were predominant tubulointerstitial lesions with a variable degree of glomerulosclerosis, with serum creatinine levels <2 mg/dL in the majority.

In a recent follow-up study using verbal autopsies in the region, CKD was identified as the primary cause of death among 133 deaths, accounting for 45% of all deaths in the region. For context, in the Million Death Study, conducted across all of India, CKD was determined to be the cause of 2.9% of the deaths among persons 15 to 69 years of age.

Challenges to Detection Efforts

Despite substantial coverage in the popular media, robust data on the burden of CKDu globally remain sparse outside of a few intensely studied regions in Central America and South Asia. In part, this reflects the challenges of capturing estimates of disease in the populations affected, which are typically served by poorly developed health systems and which have inadequate access to care (including kidney replacement therapy). This means routine health record data sources, such as death certificates or dialysis registries, can only provide limited insights into the disease burden and risk factors in most regions.

Efforts to characterize the prevalence of CKDu using population-representative surveys are ongoing. , These studies are resource intensive as eGFR testing based on blood sampling is required to define cases, given that urinary abnormalities are not typical in CKDu. eGFR test values can in turn be challenging to interpret as alongside interlaboratory variability, neither eGFR estimating equations nor the healthy population distribution of the measured GFR are generalizable across regions. The epidemiologic study designs used typically include only a single measure of eGFR without confirmation of chronicity, which may overestimate CKD prevalence. These studies also have limitations surrounding (often variable) case definitions for CKDu. Differentiating cases of CKDu from other causes of CKD is challenging even at the individual level, and pragmatic definitions such as the absence of significant proteinuria, hypertension, and diabetes (and sometimes retroviral disease and nephrotoxic drug use) are necessary in epidemiologic studies. These factors all inevitably lead to misclassification because 1. not all CKD is CKDu even in endemic areas; 2. both diabetes and hypertension, although not features of the disease, can clearly coexist with CKDu; and 3. there are cases of nonproteinuric CKD (e.g., due to drugs and genetic disorders or of unclear etiology) in all regions (i.e., including high-income nonagricultural settings), although this constellation likely does not represent the same clinical entity as the “CKDu” disease(s) described in this chapter. Nonetheless, assuming the contribution of any misclassification is low, as will be the case where there are high levels of CKDu, these studies can still provide valuable insight into the burden of, and risk factors for, CKDu across different regions globally. A number of population-representative studies conducted in areas of reported high CKDu burden, or with the specific aim of studying CKDu prevalence, are summarized in Table 83.2 .

Table 83.2

Summary of Chronic Kidney Disease of Unknown Etiology Detection Efforts in Cross-Sectional Population-Based Studies

Reference Year Published Sub-Continent Country and Region N Exclusion of Diabetes Exclusion of Hypertension (Threshold) Exclusion of Proteinuria (Threshold) Other Exclusions Chronicity Demonstrated % eGFR <60 mL/min/1.73 m 2 Independent Risk Factors for CKD/CKDu as defined by eGFR <60 mL/min/1.73 m 2
O’Donnell et al. 2011 Central America Leon, Nicaragua 771 N
but low prevalence
N N N 13% Age
Male sex
Low altitude
Torres et al. 2010 Central America Leon and Chinandega, Nicaragua 1096 N
but low prevalence
N N N 8.7% Age
Male sex
Agricultural or mining communities
Peraza et al.
https://doi.org/10.1053/j.ajkd.2011.11.039
2012 Central America Pacific Coast, El-Salvador 664 N
but low prevalence
N N N 0% in high altitude/urban areas
10% in sugarcane communities
Age
Male sex
Low Altitude
Sugarcane/cotton work
Tobacco use (males only)
Kidney stones (males only)
Diabetes (females only)
Hypertension (females only)
Orantes et al. 2011 Central America Bajo Lempa, El-Salvador 775 Y Y N Y 3.6% Age
Male sex
Family history of CKD
Miller et al.
https://doi.org/10.1016/j.ekir.2020.12.015
2021 Central America Tecpán, Guatemala and San Antonio Suchitepéquez, Guatemala 807 N N N N (Sensitivity analysis only) 4.0% Age
Diabetes
Hypertension
Low BMI
Sugarcane work in poorer participants
Ruiz-Alejos et al. 2021 South America Tumbes, Peru 1,514 Y Y (140/90) Y N 0.9% Numbers too small to undertake adjusted analyses in those without hypertension or diabetes
O’Callaghan-Gordo et al. 2019 South Asia Chennai, Visakhapatnam,
Haryana and Delhi, India
12,500
(after exclusion of diabetes and hypertension)
Y Y (140/90) Y N 1.4% Urban Northern areas
1.9% Rural Northern areas
0.43% Urban Southern area
4.8% Rural Southern area
Age
Rural residence (Southern areas only)
Fewer years of education
Tatapudi et al. 2019 South Asia Uddanam, India 2210 Y Y (140/90 for more than 5 years) Y
(PCR >1000 mg/g)
N 13.3% Age
Gummidi et al. 2020 South Asia Uddanam, India 2419 N N N Y 10.2% Age
Male sex
Hypertension
Tobacco use
Lack of formal education
Outdoor work
Family history of CKD
Analgesic use
Ruwanpathirana et al. 2019 South Asia Anuradhapura district, Sri Lanka 4803 Y Y (140/90) Y (ACR >300 mg/g) 3.7% in lowest impacted area
8.5% in highest impacted area
Age
Male sex
Family history of CKD
Tobacco use (males only)
Jayatilake et al. 2013 South Asia Anuradhapura, Badulla, Hambantota and Polonnaruwa districts, Sri Lanka 4957 Y Y (160/90) N N NA
Proteinuria screening only
Hathaway et al. 2023 Sub-Saharan Africa Kisumu, Kenya 782 Y Y Y HIV N 0% NA
Hamilton et al. 2020 Sub-Saharan Africa Lilongwe and Karonga district Malawi 821 Y Y (140/90) Y 0.2% NA
Aekplakorn et al. 2023 Southeast Asia National, Thailand 17,329 Y Y (140/90) Y (urinalysis >1+) Age>70 N 0.7% Central, South and Bangkok regions
1.6% Northeast region
Age
Female sex
Gout
Kidney stones
Rural residence
Analgesic use
Manual labour/agricultural work
Low BMI

Due to the differences in population age structures and the other limitations described earlier, the results of the above studies are not directly comparable, although a number of common themes can be identified.

Firstly, where CKDu epidemics are reported, population rates of eGFR <60 mL/min are typically ≥5% when those with diabetes, hypertension, and proteinuria are excluded and chronicity is not confirmed. Estimates would be expected to be 1% to 2% or lower using the same criteria (assuming similarly young populations) in non-CKDu–endemic regions.

Second, a number of risk factors are common across these studies. These include age (which is a risk factor for all forms of CKD), male sex, lower altitude, tobacco smoking, and lower levels of education/higher levels of poverty. Finally, agricultural (specifically sugarcane) work, rural residence, or residence in an agricultural community are also typically identified as risk factors, although distinguishing the occupational from residence-related risk factors is not always possible in many of these studies.

Biopsy findings

As with previous endemic nephropathies, kidney biopsy studies in these current CKDu-endemic regions are limited but consistent with a tubulointerstitial disease, showing mainly tubular atrophy with interstitial fibrosis and glomerulosclerosis related to ischemia, without immune complexes , ( Fig. 83.5 ). One of the first case series describing pathology findings reported data from eight men with serum creatinine ranging from 1.1 to 2.7 mg/dL, and this case series described both significant interstitial fibrosis and glomerulosclerosis. In fact, tubulitis and interstitial inflammation, although described, were not severe. However, studies from both Sri Lanka and Nicaragua recruited patients with “acute symptoms” (e.g., dysuria, fever, and AKD) from CKDu-endemic regions and showed features of acute interstitial nephritis (i.e., tubulitis and inflammatory infiltrate in the tubules , , , ), with changes in the glomeruli confined to areas with chronic interstitial damage. Assuming this clinical presentation represents the onset of CKDu, these studies would favor the argument that a primary tubulointerstitial disease leads to secondary glomerulosclerosis but certainly do not rule out the possibility that an ischemic insult is driving both tubulointerstitial and glomerular injury in parallel.

Fig. 83.5

Kidney biopsy findings from a tertiary care hospital in Sri Lanka.

(A) Broad bands of tubular atrophy and interstitial fibrosis with relative sparing of glomeruli. In addition to global glomerulosclerosis, this atrophic cortex shows glomeruli with periglomerular fibrosis (arrows). The preserved glomeruli are unremarkable (inset), and the immunofluorescence microscopy is negative (methanamine silver stain, ×100). (B) Active interstitial inflammation in nonatrophic cortex. The infiltrate is composed of lymphocytes admixed with a few plasma cells and rare eosinophils. The glomerulus is normal, and the interlobular artery (arrow) shows mild arteriosclerosis (hematoxylin-eosin, ×200).

Deeper review of tissue samples has brought a finding of potential interest: electron-dense lysosomal granules in the tubules. , The authors hypothesized that these granules may indicate an injury pathway similar to that instigated by calcineurin inhibition. Of note, however, is that replication studies have demonstrated these findings to be relatively nonspecific as others were able to identify similar granules in persons with known glomerular disease. Additional electron microscopic findings described include patchy podocyte foot process effacement, tubular vacuolization, and mitochondrial swelling.

Several challenges exist in describing the spectrum of kidney pathology observed with CKDu. A small sample of persons with CKDu undergoes biopsy, with quantitatively fewer biopsies available from Central America than from Sri Lanka. In Central America, patient-borne costs are higher. Lack of dedicated pathologists may present a further impediment. Even in persons with biopsies, there is tremendous heterogeneity in the level of kidney dysfunction at the time of biopsy. Thus in the existing literature, we lack sufficient numbers of cases to confidently match level of kidney dysfunction to tissue findings.

Developing molecular interrogation techniques holds promise for identification of pathognomic injury pathways (which could in turn provide clues to potential etiologies). However, application of these techniques (e.g., single-cell RNA sequencing) requires resource-intensive tissue handling and storage, further complicated by the need to transfer tissue from regional hotspots to the specialized centers with technical expertise.

Hypothesized Cause(s) of CKDu

Despite intensive efforts for more than 2 decades, some of which have garnered well-deserved attention by the lay press, as of this chapter’s writing no specific etiology is widely accepted as the primary driver of disease. The hypothesized causes span multiple domains including genetic, infectious, occupational, and environmental ( Fig. 83.6 ). The prolonged struggle to eliminate or deprioritize any of these broad domains reflects, among other factors, the failure to identify early kidney disease, matched with lack of methodologies to elicit cumulative (lifetime) measures of exposures ( Fig. 83.7 ). This in turn complicates prospective investigations which need to continue to expend resources to interrogate multiple domains.

Fig. 83.6

Hypothesized risk factors for chronic kidney disease of unknown etiology (CKDu).

The hypothesized causes of CKDu are many and include multiple domains, the measurement of which is time consuming and resource intensive.

From Rao IR, Bangera A, Nagaraju SP, et al. Chronic kidney disease of unknown aetiology: A comprehensive review of a global public health problem. Trop Med Int Health . 2023;28(8):588-600.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 3, 2026 | Posted by in NEPHROLOGY | Comments Off on Chronic Kidney Disease of Uncertain Etiology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access